Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32688906 | 0.85 | EPHX2 (0.41) | ALDH1A1EPHX2TDP1USP2ALOX15 | |
| SCHEMBL32689133 | 0.83 | MEN1 (0.43) | ALDH1A1EPHX2TDP1SIRT5MEN1 | |
| SCHEMBL11603168 | 0.83 | SIRT5 (0.54) | ALDH1A1EPHX2TDP1SIRT5MEN1 | |
| SCHEMBL32688857 | 0.82 | MEN1 (0.39) | ALDH1A1EPHX2TDP1SIRT5MEN1 | |
| SCHEMBL32688786 | 0.79 | MEN1 (0.37) | ALDH1A1EPHX2TDP1SIRT5MEN1 | |
| SCHEMBL32688563 | 0.78 | NPC1 (0.41) | ALDH1A1EPHX2SIRT5MEN1RAB9A | |
| SCHEMBL10835600 | 0.78 | NPC1 (0.42) | ALDH1A1EPHX2MEN1RAB9AKMT2A | |
| SCHEMBL32688733 | 0.77 | ALDH1A1 (0.44) | ALDH1A1EPHX2TDP1SIRT5MEN1 | |
| SCHEMBL11603911 | 0.77 | MEN1 (0.45) | ALDH1A1EPHX2SIRT5MEN1RAB9A | |
| SCHEMBL32688972 | 0.77 | NPC1 (0.40) | ALDH1A1EPHX2MEN1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | ALDH1A1 804/4885EPHX2 154/4885TDP1 2948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.